Oxacillin- and mupirocin-resistant Staphylococcus aureus: In vitro activity of silver sulphadiazine and cerium nitrate in hospital strains

Journal of Chemotherapy

Volumn 16, Issue 5, 2004, Pages 453-458

  Schuenck, R P ^a   Dadalti, P ^a   Silva, M G ^a   Fonseca, L S ^a   Santos, K R N ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto de Pesquisas Clínicas Evandro Chagas   (Brazil)

Author keywords

Mupirocin resistance; Oxacillin resistance; Silver sulphadiazine and cerium nitrate; Staphylococcus aureus

Indexed keywords

BACTERIAL PROTEIN; CERIUM NITRATE; OXACILLIN; PENICILLIN BINDING PROTEIN 2A; PROTEIN ILES 2; PSEUDOMONIC ACID; SULFADIAZINE SILVER; UNCLASSIFIED DRUG;

AGAR GEL DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DILUTION; DRUG ACTIVITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; STAPHYLOCOCCUS AUREUS;

EID: 8544255517     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.5.453     Document Type: Article

References (35)

1. Maranan MC, Moreira B, Boyle-Vavra S, Daum RS. Antimicrobial resistance in staphylococci: epidemiology, molecular mechanisms and clinical relevance. Infect Dis Clin North Am 1997; 11: 813-841.
2. Kluytmans J, Van Belkum A, Verbrugh H. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms and associated risks. Clin Microbiol Rev 1997; 10: 505-520.
3. Chang FY, Singh N, Gayowski T, Drenning SD, Wagener Mm, Marino IR. Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients. Transplantation 1998; 65: 1169-1172.
4. Frebourg N, Cauliez B, Lemeland JF. Evidence for nasal carriage of methicillin-resistant staphylococci colonizing intravascular devices. J Clin Microbiol 1999; 37: 1182-1185.
5. Corbella X, Dominguez MA, Pujol M, et al. Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis 1997; 16: 351-357.
6. von Eiff C, Becker K, Machka K, Stammer H, Peters G. Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med 2001; 344: 11-16.
7. Boyce JM. Preventing staphylococcal infections by eradicating nasal carriage of Staphylococcus aureus: proceeding with caution. Infect Control Hosp Epidemiol 1996; 17: 775-779.
8. Santos KRN, Fonseca LS, Gontijo Filho PP. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect Control Hosp Epidemiol 1996; 17: 24-27.
9. Rich M, Bannatyne RM, Memish ZA. Mupirocin resistance of methicillin resistant Staphylococcus aureus in Saudi Arabia. J Chemother 1999; 11: 414-415.
10. Deshpande LM, Fix AM, Pfaller MA, Jones RN, SENTRY GROUP. Emerging elevated mupirocin resistance rates among staphylococal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, E-test and reference dilution methods. Diag Microbiol Infect Dis 2002; 42: 283-290.
11. Nunes ELC, Santos KRN, Mondino PJJ, Bastos MCF, Giambiagi-De-Marval M. Detection of ileS-2 gene encoding mupirocin resistance in methicillin-resistant Staphylococcus aureus by multiplex PCR. Diag Microbiol Infect Dis 1999; 34: 77-81.
12. Bastos MCF, Mondino PJJ, Azevedo MLB, Santos KRN, Giambiagi-Demarval M. Molecular characterization and transfer among Staphylococcus strains of a plasmid confering high-level resistance to mupirocin. Eur J Clin Microbiol Infect Dis 1999; 18: 393-398.
13. Fung S, O'Grady S, Kennedy C, Deider H, Campbell I, Conly J. The utility of polysporin ointment the eradication of methicillin-resistant Staphylococcus aureus colonization: a pilot study. Infect Control Hosp Epidemiol 2000; 21: 653-655.
14. Kokai-Kum JF, Walsh SM, Chanturiya T, Mond JJ. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother 2003; 47: 1589: 1597.
15. Fox CL. Silver sulfadiazine: A new topical therapy for Pseudomonas in burns. Arch Surg 1968; 96: 184-188.
16. Marone P, Monzillo V, Perversi L, Carreto E. Comparative in vitro activity of silver sulphadiazine alone and in combination with cerium nitrate against staphylococci and Gram-negative bacteria. J Chemother 1998; 10: 17-21.
17. Gracia CG. An open study comparing topical silver sulfadiazine and topical silver sulfadiazine-ceriurn nitrate in the treatment of moderate an severe burns. Burns 2001; 27: 67-74.
18. Rosenkranz HS, Carr HS. Silver sulfadiazine: effect on the growth and metabolism of bacteria. Antimicrob Agents Chemother 1972; 2: 367.
19. Coward JE, Carr HS, Rosenkranz HS. Silver Sulphadiazine: effect on the growth and ultra structure of staphylococci. Chemotherapy 1973; 19: 348-353.
20. Monafo WW, Tandom SN, Tuchschmi DTJ, Skinner AM, Deitz F. Cerium nitrate: A new topical antiseptic for extensive burns. Surgery 1976; 80: 465-473.
21. Rosenkranz HS. A synergistic effect between cerium nitrate and silver sulphadiazine. Burns 1978; 5: 178-281.
22. Maple PA, Hamilton-Miller JMT, Brumfitt W. Comparison of the in vitro activities of the topical antimicrobials azelaic acid, nitrofurazone, silver sulphadiazine and mupirocin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 1992; 29: 661-668.
23. Hamilton-Miller JMT, Shah S, Smith C. Silver sulphadiazine: a comprehensive in vitro reassessment. Chemotherapy 1993; 39: 405-409.
24. MacFaddin JF. Biochemical Tests for Identification of Medical Bacteria. Williams & Wilkins Company, Baltimore, USA. 1976: 312.
25. Holt GH, Krieg NR, Sneath PHA, Staley JT, Williams ST. Genus Staphylococcus. In: Bergey's Manual of Determinative Bacteriology - 9th ed. Williams & Wilkins, Baltimore, USA. 1994: 532.
26. National Committee For Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility test - eighth ed. Approved standards: M2-A8. NCCLS, Wayne, Pennsylvania, USA 2003.
27. Fuchs PC, Jones RN, Barry AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990; 28: 608-609.
28. National Committee For Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - sixth ed. Approved standards. M7-A6. NCCLS, Wayne, Pennsylvania, USA 2003.
29. Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, SENTRY GROUP. Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY antimicrobial surveillance program, 1997-1999. Clin Infect Dis 2001; 32 (suppl 2): S114-132.
30. Hiramatsu K. Vancomycin resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis 2001; 1: 147-155.
31. Eltringham I. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA). J Hosp Infect 1997; 35:1-8.
32. Schitt KS, Knapp C, Hall G, Longworth DL, McMahon JT, Washington JA. Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. J Clin Microbiol 1996; 34: 508-511
33. Herruzo-Cabrera R, Gracia-Torres V, Rey-Calero J, Vizcaino-Alcaide MJ. Evaluation of the penetration strength, bactericidal efficacy and spectrum of action of several antimicrobial creams against isolated microorganisms in a burn center. Burns 1992; 18: 39-44.
34. Pirnay JP, Vos DD, Coches C et al. Molecular epidemiology of Pseudomonas aeruginosa colonization in a burn unit: persistence of a multidrug-resistant clone and a silver sulfadiazine-resistant clone. J Clin Microbiol 2003; 41: 1192-1202.
35. Caelli M, Porteous J, Carson CF, Heller R, Riley TV. Tea tree oil as an alternative topical nasal decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000; 46: 236-237.